# Nephros Inc: Form 10-K for the period ended Dec 31, 2014

- Company: [Nephros Inc](/companies/neph.md) (CIK 1196298)
- Form: 10-K
- Filed: 2015-04-15
- Accepted by EDGAR: Apr 15, 2015, 10:02 ET
- Period: 2014-12-31
- Accession: 0001144204-15-022858
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1196298/000114420415022858/v399849_10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1196298/000114420415022858/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2014-01-01 to 2014-12-31 | $1.7m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months, 2014-01-01 to 2014-12-31 | $549.0k | us-gaap:CostOfGoodsSold |
| Gross profit | 12 months, 2014-01-01 to 2014-12-31 | $1.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months, 2014-01-01 to 2014-12-31 | $2.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2014-01-01 to 2014-12-31 | −$2.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2014-01-01 to 2014-12-31 | $483.0k | us-gaap:InterestExpense |
| Net income | 12 months, 2014-01-01 to 2014-12-31 | −$7.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2014-01-01 to 2014-12-31 | −$0.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2014-01-01 to 2014-12-31 | −$0.31 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2014-01-01 to 2014-12-31 | 23,817,184 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2014-01-01 to 2014-12-31 | −$2.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | at 2014-12-31 | $1.3m | us-gaap:Cash |
| Current assets | at 2014-12-31 | $1.7m | us-gaap:AssetsCurrent |
| Total assets | at 2014-12-31 | $3.4m | us-gaap:Assets |
| Current liabilities | at 2014-12-31 | $1.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-12-31 | $9.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-12-31 | −$5.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1196298/000114420415022858/v399849_10k.htm

Filed Apr 15, 2015.
Source: SEC EDGAR, the filing index for accession 0001144204-15-022858. Last ingested by Listed: Nov 13, 2026, 16:20 ET. No prices; not investment advice.
